|
|
||||||||
Animal: RNA Viruses |
Centre de Recherche en Infectiologie, Hôpital CHUL, Centre Hospitalier Universitaire de Québec and Département de Biologie Médicale, Faculté de Médecine, Université Laval, Ste-Foy (Québec), Canada1
Author for correspondence: Michel J. Tremblay. Mailing address: Laboratoire dImmuno-Rétrovirologie Humaine, Centre de Recherche en Infectiologie, RC709, Hôpital CHUL, Centre Hospitalier Universitaire de Québec, 2705 boul. Laurier, Ste-Foy (Québec), Canada G1V 4G2. Fax +1 418 654 2212. e-mail Michel.J.Tremblay{at}crchul.ulaval.ca
Previous findings indicated that HLA-DR is probably one of the most abundant cellular constituents incorporated within the human immunodeficiency virus type 1 (HIV-1) envelope. Given that the life-cycle of HIV-1 has been reported to be modulated by virion-bound host HLA-DR, an improved version of a virus capture technique was developed to assess the degree of HLA-DR incorporation in several clinical isolates of HIV-1 derived from primary human peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages (MDM). Analysis of virus stocks purified from PBMCs and MDM indicated that primary isolates of HIV-1 bearing distinct tropism (i.e. T-, macrophage-, and dual-tropic) all incorporate host cell membrane HLA-DR protein. The amount of incorporated HLA-DR varies among the primary HIV-1 isolates tested. Propagation of some clinical HIV-1 isolates in either autologous PBMCs or MDM resulted in differential incorporation of virion-bound cellular HLA-DR depending on the nature of the virus producer cells. Differences in the degree of HLA-DR incorporation were also noticed when macrophage-tropic isolates of HIV-1 were produced in MDM from different donors. Altogether these data show that the efficiency of HLA-DR incorporation into the envelope of primary isolates of HIV-1 is a multifactorial phenomenon since it is affected by the virus isolate itself, the nature of host cells (i.e. PBMCs or MDM) and the donor source.
This article has been cited by other articles:
![]() |
S. M. Wahl, T. Greenwell-Wild, and N. Vazquez HIV accomplices and adversaries in macrophage infection J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ono, A. A. Waheed, A. Joshi, and E. O. Freed Association of Human Immunodeficiency Virus Type 1 Gag with Membrane Does Not Require Highly Basic Sequences in the Nucleocapsid: Use of a Novel Gag Multimerization Assay J. Virol., November 15, 2005; 79(22): 14131 - 14140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Tardif and M. J. Tremblay LFA-1 Is a Key Determinant for Preferential Infection of Memory CD4+ T Cells by Human Immunodeficiency Virus Type 1 J. Virol., November 1, 2005; 79(21): 13714 - 13724. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cantin, S. Methot, and M. J. Tremblay Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses J. Virol., June 1, 2005; 79(11): 6577 - 6587. [Full Text] [PDF] |
||||
![]() |
J. Roy, G. Martin, J.-F. Giguere, D. Belanger, M. Petrin, and M. J. Tremblay HIV Type 1 Can Act as an APC upon Acquisition from the Host Cell of Peptide-Loaded HLA-DR and CD86 Molecules J. Immunol., April 15, 2005; 174(8): 4779 - 4788. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Beausejour and M. J. Tremblay Interaction between the Cytoplasmic Domain of ICAM-1 and Pr55Gag Leads to Acquisition of Host ICAM-1 by Human Immunodeficiency Virus Type 1 J. Virol., November 1, 2004; 78(21): 11916 - 11925. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gummuluru, M. Rogel, L. Stamatatos, and M. Emerman Binding of Human Immunodeficiency Virus Type 1 to Immature Dendritic Cells Can Occur Independently of DC-SIGN and Mannose Binding C-Type Lectin Receptors via a Cholesterol-Dependent Pathway J. Virol., December 1, 2003; 77(23): 12865 - 12874. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Polyanskaya, S. A. Sharpe, N. Cook, S. Leech, and M. P. Cranage Infection of macaques with simian immunodeficiency virus induces a species-specific antibody response to major histocompatibility complex class I and class II molecules J. Gen. Virol., July 1, 2003; 84(7): 1671 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Giguere, J.-S. Paquette, S. Bounou, R. Cantin, and M. J. Tremblay New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 J. Immunol., September 1, 2002; 169(5): 2762 - 2771. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |